
Join to view full profile
5841 S Maryland AveChicago, IL 60637
Phone+1 888-824-0200
Dr. Vokes is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1983 - 1986
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1982 - 1983
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1980 - 1982
University of Bonn Faculty of MedicineClass of 1980
Certifications & Licensure
IL State Medical License 1981 - 2029
IN State Medical License 2023 - 2027
WI State Medical License 2022 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
- Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer
Publications & Presentations
PubMed
- Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.Jamie E Chaft, Zhuoxin Sun, Charles M Rudin, Onkar V Khullar, Charles B Simone 2nd
JAMA. 2026-08-11 - Project Optimus for Radiation Therapy-Drug Combinations: Moving Beyond the Maximum Tolerated Dose.Alastair Greystoke, Sarah Brown, Anthony Chalmers, Jamie A Dean, Eric Deutsch
International Journal of Radiation Oncology, Biology, Physics. 2026-07-30 - Comprehensive multi-omic dissection and AI-prioritized target identification in inverted papilloma-associated sinonasal squamous cell carcinoma.Alka Singh, Michael Korzinkin, Viktoria Sarkisova, Ekaterina Vergasova, Ari J Rosenberg
NPJ Precision Oncology. 2026-07-10
Journal Articles
- OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal CancerL Portugal, E A Blair, J M Melotek, M W Lingen, N Agrawal, A Dekker, Z Gooi, D T Ginat, C C Foster, E E Vokes, D J Haraf, Annals of Oncology
Other
- Locally advanced squamous cell carcinoma of the head and neck: Approaches combining chemotherapy and radiation therapyVokes EE, Brockstein BE
http://www.uptodate.com/contents/locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-appro
UpToDate, Wolters Kluwer Health - 2013-04-12 - Methods to overcome radiation resistance in head and neck cancerVokes EE, Brockstein BE, Yoo DS
http://www.uptodate.com/contents/methods-to-overcome-radiation-resistance-in-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2012-04-20 - Treatment of metastatic and recurrent head and neck cancerVokes EE, Brockstein BE
http://www.uptodate.com/contents/treatment-of-metastatic-and-recurrent-head-and-neck-cancer
UpToDate, Wolters Kluwer Health - 2013-03-05
Press Mentions
Harvey Golomb, Former Chair of the Department of Medicine, 1943–2025August 26th, 2025
Radiation Oncology Physician Groups Unite to Ensure Patient Access to Cancer CareJanuary 9th, 2024
New Study Supports Saving More Lung Tissue in Lung Cancer SurgeriesMarch 24th, 2023
Grant Support
- Program 4 (Clinical And Experimental Therapeutics)National Cancer Institute2008–2012
- Tas:: 75 0850 ::Tas Recovery ACT - Actnow Clinical Trial 8418 UnderDivision Of Cancer Treatment2009
- Early Therapeutics Development With Phase II EmphasisDivision Of Cancer Treatment2009
- Early Therapeutics Development With Phase II EmphasisNational Cancer Institute2007
- Carcinogenesis And Novel Therapeutics In Oral CancerNational Institute Of Dental &Craniofacial Research1996–2001
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









